Long-term management of chronic spontaneous urticaria with omalizumab
Author:
Affiliation:
1. Dermatology Department; Coimbra University Hospital Centre; Coimbra Portugal
2. Clinic of Dermatology; Faculty of Medicine; University of Coimbra; Coimbra Portugal
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ced.13173/fullpdf
Reference18 articles.
1. BSACI guidelines for the management of chronic urticaria and angio-oedema;Powell;Clin Exp Allergy,2007
2. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update;Zuberbier;Allergy,2014
3. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria;Staevska;J Allergy Clin Immunol,2010
4. Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study;Saini;J Invest Dermatol,2015
5. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria;Maurer;N Engl J Med,2013
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cutaneous Photosensitivity Diseases;Rook's Textbook of Dermatology;2024-03-19
2. Association Between Serum Total IgE Levels and Clinical Response to Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis;The Journal of Allergy and Clinical Immunology: In Practice;2023-08
3. Scientific landscape and trend analysis of chronic urticaria: a two-decade bibliometric review;European Journal of Dermatology;2023-08
4. Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria;International Journal of Molecular Sciences;2023-07-11
5. Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know;American Journal of Clinical Dermatology;2023-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3